A recent study found that inhibiting mitochondrial COX-2 improves chemosensitivity in HCC by modulating mitochondrial dynamics through dynamin-related protein 1 (Drp1) [36]. The gene discussed is DNM1L; the disease is hepatocellular carcinoma.